Spike-specific CXCR3+ TFH cells show superior capacity to spike-specific CXCR3− TFH cells in supporting antibody-secreting cell differentiation in both COVID-19 convalescents and vaccinees. This evidence concerns the gene CXCR3 and COVID-19.